Ibrutinib and Venetoclax for First-Line Treatment of CLL. Reply
- PMID: 31433937
- DOI: 10.1056/NEJMc1908754
Ibrutinib and Venetoclax for First-Line Treatment of CLL. Reply
Comment on
-
Ibrutinib and Venetoclax for First-Line Treatment of CLL.N Engl J Med. 2019 Aug 22;381(8):788-789. doi: 10.1056/NEJMc1908754. N Engl J Med. 2019. PMID: 31433936 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources